Guillain-Barre syndrome following the first dose of SARS-CoV-2 vaccine, Oxford/AstraZeneca (ChAdOx1) / Síndrome de Guillain-Barre após a primeira dose da vacina contra a SRA-CoV-2, Oxford/AstraZeneca (ChAdOx1)
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2022 |
| Outros Autores: | , , , , , , , |
| Tipo de documento: | Artigo |
| Idioma: | eng |
| Título da fonte: | Brazilian Journal of Health Review |
| Texto Completo: | https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/44482 |
Resumo: | In the United Kingdom, until 04/21, 6 patients with SGB after the ChAdOx1 were notified out of a total of 42.917 vaccinated, with an 80% reduction in hospitalization in the elderly after vaccination. Facts added to the global pandemic scenario, the vaccine remains necessary. |
| id |
BJRH-0_0484f7062f796bac886ff735d0689c3c |
|---|---|
| oai_identifier_str |
oai:ojs2.ojs.brazilianjournals.com.br:article/44482 |
| network_acronym_str |
BJRH-0 |
| network_name_str |
Brazilian Journal of Health Review |
| repository_id_str |
|
| spelling |
Guillain-Barre syndrome following the first dose of SARS-CoV-2 vaccine, Oxford/AstraZeneca (ChAdOx1) / Síndrome de Guillain-Barre após a primeira dose da vacina contra a SRA-CoV-2, Oxford/AstraZeneca (ChAdOx1)ChAdOxSARS-CoV-2 vaccineGuillain-Barre syndromeAstraZeneca.In the United Kingdom, until 04/21, 6 patients with SGB after the ChAdOx1 were notified out of a total of 42.917 vaccinated, with an 80% reduction in hospitalization in the elderly after vaccination. Facts added to the global pandemic scenario, the vaccine remains necessary.Brazilian Journals Publicações de Periódicos e Editora Ltda.2022-02-23info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/4448210.34119/bjhrv5n1-314Brazilian Journal of Health Review; Vol. 5 No. 1 (2022); 3638-3641Brazilian Journal of Health Review; v. 5 n. 1 (2022); 3638-36412595-6825reponame:Brazilian Journal of Health Reviewinstname:Federação das Indústrias do Estado do Paraná (FIEP)instacron:BJRHenghttps://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/44482/pdfCopyright (c) 2022 Brazilian Journal of Health Reviewinfo:eu-repo/semantics/openAccessde Jesus, Tatiane Arroyo Lopes AlvesAndre, Amanda Leticia AndreDircksen, Nathalye Fernanda PedrosoMarinho, Arthur CoelhoCarvalho, Marcelo Simpliciodos Santos, Breno William CorreaJunior, Walton Luiz Del TedescoKawagoe, Kleber EdsonKaimen-Maciel, Damacio Ramon2022-02-28T20:37:42Zoai:ojs2.ojs.brazilianjournals.com.br:article/44482Revistahttp://www.brazilianjournals.com/index.php/BJHR/indexPRIhttps://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/oai|| brazilianjhr@gmail.com2595-68252595-6825opendoar:2022-02-28T20:37:42Brazilian Journal of Health Review - Federação das Indústrias do Estado do Paraná (FIEP)false |
| dc.title.none.fl_str_mv |
Guillain-Barre syndrome following the first dose of SARS-CoV-2 vaccine, Oxford/AstraZeneca (ChAdOx1) / Síndrome de Guillain-Barre após a primeira dose da vacina contra a SRA-CoV-2, Oxford/AstraZeneca (ChAdOx1) |
| title |
Guillain-Barre syndrome following the first dose of SARS-CoV-2 vaccine, Oxford/AstraZeneca (ChAdOx1) / Síndrome de Guillain-Barre após a primeira dose da vacina contra a SRA-CoV-2, Oxford/AstraZeneca (ChAdOx1) |
| spellingShingle |
Guillain-Barre syndrome following the first dose of SARS-CoV-2 vaccine, Oxford/AstraZeneca (ChAdOx1) / Síndrome de Guillain-Barre após a primeira dose da vacina contra a SRA-CoV-2, Oxford/AstraZeneca (ChAdOx1) de Jesus, Tatiane Arroyo Lopes Alves ChAdOx SARS-CoV-2 vaccine Guillain-Barre syndrome AstraZeneca. |
| title_short |
Guillain-Barre syndrome following the first dose of SARS-CoV-2 vaccine, Oxford/AstraZeneca (ChAdOx1) / Síndrome de Guillain-Barre após a primeira dose da vacina contra a SRA-CoV-2, Oxford/AstraZeneca (ChAdOx1) |
| title_full |
Guillain-Barre syndrome following the first dose of SARS-CoV-2 vaccine, Oxford/AstraZeneca (ChAdOx1) / Síndrome de Guillain-Barre após a primeira dose da vacina contra a SRA-CoV-2, Oxford/AstraZeneca (ChAdOx1) |
| title_fullStr |
Guillain-Barre syndrome following the first dose of SARS-CoV-2 vaccine, Oxford/AstraZeneca (ChAdOx1) / Síndrome de Guillain-Barre após a primeira dose da vacina contra a SRA-CoV-2, Oxford/AstraZeneca (ChAdOx1) |
| title_full_unstemmed |
Guillain-Barre syndrome following the first dose of SARS-CoV-2 vaccine, Oxford/AstraZeneca (ChAdOx1) / Síndrome de Guillain-Barre após a primeira dose da vacina contra a SRA-CoV-2, Oxford/AstraZeneca (ChAdOx1) |
| title_sort |
Guillain-Barre syndrome following the first dose of SARS-CoV-2 vaccine, Oxford/AstraZeneca (ChAdOx1) / Síndrome de Guillain-Barre após a primeira dose da vacina contra a SRA-CoV-2, Oxford/AstraZeneca (ChAdOx1) |
| author |
de Jesus, Tatiane Arroyo Lopes Alves |
| author_facet |
de Jesus, Tatiane Arroyo Lopes Alves Andre, Amanda Leticia Andre Dircksen, Nathalye Fernanda Pedroso Marinho, Arthur Coelho Carvalho, Marcelo Simplicio dos Santos, Breno William Correa Junior, Walton Luiz Del Tedesco Kawagoe, Kleber Edson Kaimen-Maciel, Damacio Ramon |
| author_role |
author |
| author2 |
Andre, Amanda Leticia Andre Dircksen, Nathalye Fernanda Pedroso Marinho, Arthur Coelho Carvalho, Marcelo Simplicio dos Santos, Breno William Correa Junior, Walton Luiz Del Tedesco Kawagoe, Kleber Edson Kaimen-Maciel, Damacio Ramon |
| author2_role |
author author author author author author author author |
| dc.contributor.author.fl_str_mv |
de Jesus, Tatiane Arroyo Lopes Alves Andre, Amanda Leticia Andre Dircksen, Nathalye Fernanda Pedroso Marinho, Arthur Coelho Carvalho, Marcelo Simplicio dos Santos, Breno William Correa Junior, Walton Luiz Del Tedesco Kawagoe, Kleber Edson Kaimen-Maciel, Damacio Ramon |
| dc.subject.por.fl_str_mv |
ChAdOx SARS-CoV-2 vaccine Guillain-Barre syndrome AstraZeneca. |
| topic |
ChAdOx SARS-CoV-2 vaccine Guillain-Barre syndrome AstraZeneca. |
| description |
In the United Kingdom, until 04/21, 6 patients with SGB after the ChAdOx1 were notified out of a total of 42.917 vaccinated, with an 80% reduction in hospitalization in the elderly after vaccination. Facts added to the global pandemic scenario, the vaccine remains necessary. |
| publishDate |
2022 |
| dc.date.none.fl_str_mv |
2022-02-23 |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.uri.fl_str_mv |
https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/44482 10.34119/bjhrv5n1-314 |
| url |
https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/44482 |
| identifier_str_mv |
10.34119/bjhrv5n1-314 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/44482/pdf |
| dc.rights.driver.fl_str_mv |
Copyright (c) 2022 Brazilian Journal of Health Review info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
Copyright (c) 2022 Brazilian Journal of Health Review |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Brazilian Journals Publicações de Periódicos e Editora Ltda. |
| publisher.none.fl_str_mv |
Brazilian Journals Publicações de Periódicos e Editora Ltda. |
| dc.source.none.fl_str_mv |
Brazilian Journal of Health Review; Vol. 5 No. 1 (2022); 3638-3641 Brazilian Journal of Health Review; v. 5 n. 1 (2022); 3638-3641 2595-6825 reponame:Brazilian Journal of Health Review instname:Federação das Indústrias do Estado do Paraná (FIEP) instacron:BJRH |
| instname_str |
Federação das Indústrias do Estado do Paraná (FIEP) |
| instacron_str |
BJRH |
| institution |
BJRH |
| reponame_str |
Brazilian Journal of Health Review |
| collection |
Brazilian Journal of Health Review |
| repository.name.fl_str_mv |
Brazilian Journal of Health Review - Federação das Indústrias do Estado do Paraná (FIEP) |
| repository.mail.fl_str_mv |
|| brazilianjhr@gmail.com |
| _version_ |
1797240072797421568 |